BCL2 and gastric cancer: Studies have reported that a novel ceRNA activity of lncRNA MEG3 in human gastric cancer cells, lncRNA MEG3 inhibits the cell proliferation, migration and invasion in gastric cancer by competitively binding the miR-181 family, upregulating Bcl-2, and suppressing gastric carcinogenesis [20].